Women’s health company Minerva Surgical (Nasdaq:UTRS) announced that it appointed Kaile Zagger as its new chief commercial officer.
Zagger’s role includes helping to guide the strategic growth of the company as it advances in the women’s healthcare space.
“We are excited to have Kaile as our new Chief Commercial Officer for her proven track record of driving exponential growth and productivity while delivering bottom-line results,” said Todd Usen, president and CEO of Minerva Surgical.
Usen, the former Activ Surgical CEO, took over the corner office at Minerva at the beginning of the year. The company develops abnormal uterine bleeding (AUB) treatments. It closed a private placement worth $30 million last month.
“Beyond her professional acumen, Ms. Zagger’s passion for channeling her leadership experience into companies that improve the quality of healthcare for women and children a…